LakePharma Announces Dedicated Vector Center to Support Gene and Cell TherapyAdded On: 2019-02-26
LakePharma Announces its GMP Biorepository Facility near Boston is Now Operational, Plans Additional HiringAdded On: 2019-01-15
LakePharma announces its cGMP microBiomanufacturing Center is now operationalAdded On: 2018-12-18
Added On: 2016-06-22
The presentation, titled “Rapid, Scalable Production of Recombinant Proteins and Stable Cell Lines”, will focus on consistency in product quality between transient gene expressions and that of stable cell lines. Dr. Tu will join MaxCyte Vice President of Technical Applications and Customer Service James Brady in demonstrating the rapid production of proteins and cell lines at different scales with optimal efficiency. The impact that more efficient protein production has on drug development and selection will be emphasized in Dr. Tu’s speech, proof of which is demonstrated daily in LakePharma’s stable cell line generation platform.
Click here for more information on the event.